Ownership history in NKCFO LLC · 6 quarters on record
This page tracks every 13F SEC filing in which NKCFO LLC reported a position in GLAXOSMITHKLINE PLC (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 66,800 | -151,400 | -69.4% | 0.95% | $3.3M | $48.65 |
| 2022 Q3 | REDUCED | 218,200 | -51,300 | -19.0% | 2.97% | $6.4M | $25.64 |
| 2022 Q2 | UNCHANGED | 269,500 | — | 0% | 4.13% | $11.7M | $37.49 |
| 2022 Q1 | UNCHANGED | 269,500 | — | 0% | 3.65% | $11.7M | $37.22 |
As of 2025 Q4 — sorted by position size